SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-144744
Filing Date
2023-05-15
Accepted
2023-05-15 14:09:54
Documents
44
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d234197d10q.htm   iXBRL 10-Q 565320
2 EX-31.1 d234197dex311.htm EX-31.1 11457
3 EX-31.2 d234197dex312.htm EX-31.2 11469
4 EX-32.1 d234197dex321.htm EX-32.1 4352
5 EX-32.2 d234197dex322.htm EX-32.2 4289
  Complete submission text file 0001193125-23-144744.txt   3399682

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20230331.xsd EX-101.SCH 31052
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20230331_cal.xml EX-101.CAL 17831
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20230331_def.xml EX-101.DEF 188010
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20230331_lab.xml EX-101.LAB 233611
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20230331_pre.xml EX-101.PRE 222198
38 EXTRACTED XBRL INSTANCE DOCUMENT d234197d10q_htm.xml XML 462866
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40131 | Film No.: 23920880
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences